Development of a Cancer Nanovaccine to Induce Antigen-specific Immune Responses Based on Large-Sized Porous Silica Nanoparticles.

Shin, Hojeong; Kang, Seounghun; Chae, Se-Youl; Won, Cheolhee; Min, Dal-Hee

Shin, Hojeong; Kang, Seounghun; Chae, Se-Youl; Won, Cheolhee; Min, Dal-Hee.

Afiliación

Shin H; Department of Chemistry, Seoul National University, Seoul 08826, Republic of Korea.
Kang S; Department of Chemistry, Seoul National University, Seoul 08826, Republic of Korea.
Chae SY; Department of Chemistry, Seoul National University, Seoul 08826, Republic of Korea.
Won C; Institute of Biotherapeutics Convergence Technology, Lemonex Inc., Seoul 06683, Republic of Korea.
Min DH; Department of Chemistry, Seoul National University, Seoul 08826, Republic of Korea.

ACS Appl Mater Interfaces ; 2023 Mar 13.

Article en En | MEDLINE | ID: mdl-36913611

Palabras clave

anticancer immunity; antigen depot; cancer immunotherapy; nanovaccine; silica nanoparticles

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: ACS Appl Mater Interfaces Asunto de la revista: BIOTECNOLOGIA / ENGENHARIA BIOMEDICA Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google